2004Journal of Medical ForumRequires access

Effects of Xuezhikang on Treatment of Primary Hyperlipidemia

Bing Wang

Open publisher page 2 citations

Abstract

Objective To evaluate the effect of Xuezhikang on the patients with primary hyperlipidemia.Methods 84 patients with primary hyperlipidemia were divided into treatment (Xuezhikang) group(n=42) and control group (Inositol hexanicotinate)(n=42).Treatment group was given Xuezhi kang 2 capsules every time,b.i.d, control group was given inositol hexanicotinate 200mg/time,t.i.d for 8 weeks.The serum levels of lipidemia were detected before and after treatment.Results The serum levels of TG,TC both decreased (P0.01),HDL-C were increased in both of two groups(P0.01),compared the difference (d) of TC,TG and TC-HDL-C/HDL-C before and after treatment,the effect of treatment group dereasing TC,TG and HC-HDL-ch/HDL-ch is obvious better than that of control group,so does its effect of increasing HDL-ch..Conclusion Xuezhikang is an effective and safe lipidmodulator with less side-effects.

About this research paper

What this paper is about

Objective To evaluate the effect of Xuezhikang on the patients with primary hyperlipidemia.Methods 84 patients with primary hyperlipidemia were divided into treatment (Xuezhikang) group(n=42) and control group (Inositol hexanicotinate)(n=42).Treatment group was given Xuezhi kang 2 capsules every time,b.i.d, control group was given inositol hexanicotinate 200mg/time,t.i.d for 8 weeks.The serum levels of lipidemia were detected before and after treatment.Results The serum levels of TG,TC both decreased (P0.01),HDL-C were increased in both of two groups(P0.01),compared the difference (d) of TC,TG and TC-HDL-C/HDL-C before and after treatment,the effect of treatment group dereasing TC,TG and HC-HDL-ch/HDL-ch is obvious better than that of control group,so does its effect of increasing HDL-ch..Conclusion Xuezhikang is an effective and safe lipidmodulator with less side-effects.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effect of Xuezhikang on the patients with primary hyperlipidemia.Methods 84 patients with primary hyperlipidemia were divided into treatment (Xuezhikang) group(n=42) and control group (Inositol hexanicotinate)(n=42).Treatment group was given Xuezhi kang 2 capsules every time,b.i.d, control group was given inositol hexanicotinate 200mg/time,t.i.d for 8 weeks.The serum levels of lipidemia were detected before and after treatment.Results The serum levels of TG,TC both decreased (P0.01),HDL-C were increased in both of two groups(P0.01),compared the difference (d) of TC,TG and TC-HDL-C/HDL-C before and after treatment,the effect of treatment group dereasing TC,TG and HC-HDL-ch/HDL-ch is obvious better than that of control group,so does its effect of increasing HDL-ch..Conclusion Xuezhikang is an effective and safe lipidmodulator with less side-effects.

Key concepts: Hyperlipidemia, Internal medicine, Medicine, Gastroenterology, Blood lipids, Endocrinology, Cholesterol, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Xuezhikang on Treatment of Primary Hyperlipidemia — Research Paper | ScholarLens